Market Tracker

06/30 6:02pm ET

Enzon Pharmaceuticals Inc (NASDAQ:ENZN)

1.20
Delayed Data
As of Jun 30
 +0.03 / +2.56%
Today’s Change
0.78
Today|||52-Week Range
1.88
+21.33%
Year-to-Date
No recent news for Enzon Pharmaceuticals Inc.

Today’s Trading

Previous close1.17
Today’s open1.18
Day’s range1.17 - 1.21
Volume289,053
Average volume (3 months)2,942,943
Market cap$51.7M
Dividend yield--
Data as of 4:00pm ET, 06/30/2015

Growth & Valuation

Earnings growth (last year)+82.79%
Earnings growth (this year)--
Earnings growth (next 5 years)+53.00%
Revenue growth (last year)-9.63%
P/E ratio1.9
Price/Sales1.55
Price/Book1.75

Competitors

 Today’s
change
Today’s
% change
ONTXOnconova Therapeutic...0.000.00%
NYMXNymox Pharmaceutical...-0.04-2.92%
HTBXHeat Biologics Inc0.000.00%
OGXIOncoGenex Pharmaceut...+0.08+3.56%
Data as of 4:00pm ET, 06/30/2015

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$31.2M
Annual profit (last year)$28.8M
Net profit margin92.37%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer, COO &
Secretary
George W. Hebard
Chief Financial Officer &
Vice President
Richard L. Feinstein
Corporate headquarters
Piscataway, New Jersey

Forecasts